申请人:Shionogi & Co., Ltd.
公开号:US10011613B2
公开(公告)日:2018-07-03
The present invention relates to a novel compound having an antiviral effect, more specifically, a pyridone derivative having HIV integrase inhibitory activity, and a medicament containing the same, in particular, an anti-HIV agent. The compound of the present invention has integrase inhibitory activity and/or cell proliferation inhibitory activity against viruses, in particular, HIV and drug-resistant strains thereof. Thus, the compound is useful in preventing or treating various diseases, viral infections (for example, AIDS), and the like in which integrase participates.
本发明涉及一种具有抗病毒作用的新型化合物,更具体地说,是一种具有艾滋病病毒整合酶抑制活性的吡啶酮衍生物,以及含有该化合物的药物,特别是抗艾滋病病毒药物。本发明的化合物对病毒,特别是艾滋病毒及其耐药菌株具有整合酶抑制活性和/或细胞增殖抑制活性。因此,本发明化合物可用于预防或治疗整合酶参与的各种疾病、病毒感染(如艾滋病)等。